Chronic Inflammation in Patients with Chronic Coronary Syndrome Who Have Been Taking Lipid-Lowering Drugs as a

Runze Zhu1,2,3, Wenxian Wang1,2,3, Yan Gao2,3

  • 1School of Radiology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, People's Republic of China.

PubMed

Insights

In patients with chronic coronary syndrome on statins, high systemic inflammation (SIRI) and epicardial adipose tissue (EAT) volume are key risk factors for adverse events. These factors interact, worsening prognosis beyond lipid levels.

Area of Science:

  • Cardiology
  • Biomedical research
  • Inflammation research

Background:

  • Patients with coronary heart disease on long-term lipid-lowering agents often have low lipid levels but remain at risk due to systemic inflammation.
  • Elevated systemic inflammation is a significant risk factor for poor prognosis in individuals with chronic coronary syndrome (CCS).

Purpose of the Study:

  • To investigate the relationship between systemic inflammation and adverse outcomes in CCS patients.
  • To explore the synergistic interaction between systemic inflammation and epicardial adipose tissue (EAT) in CCS patients.

Main Methods:

  • A retrospective cohort study of 278 CCS patients on long-term statin therapy.
  • Cardiovascular magnetic resonance (CMR) imaging and blood tests were used to measure EAT volume and systemic inflammatory response index (SIRI).
  • Cox regression and mediation analyses were employed to assess associations and interrelationships.

Main Results:

  • Both SIRI and indexed EAT volume were independently associated with major adverse cardiovascular events (MACEs).
  • Combining SIRI and EAT volume improved MACE prediction.
  • EAT volume and SIRI showed a bidirectional partial mediation effect on MACEs and extracellular volume (ECV).

Conclusions:

  • Elevated SIRI and increased EAT volume are critical risk factors in CCS patients on statins, surpassing lipid levels.
  • SIRI and EAT volume interact, collectively contributing to a poor prognosis in this patient group.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
850
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
296
Inflammation01:38

Inflammation

Overview
61.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
342
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
818
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.2K